Oncolytics Biotech Inc. (USA) (NASDAQ:ONCY) falls from high, U.S. Geothermal Inc. (NYSEMKT:HTM)

Posted by Beth Hart May 22, 2013 0 Comment 1141 views


Miami, FL 05/22/2013 (GDPInsider) – Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) opened the day at $2.97 and hit a high of $3.06 and a low of $2.83 and is currently down by 1.10% to trade at $2.69, with a volume of about 1.60 million. The institutions have collected about 2.45% of the total 84.76 million shares outstanding. The short ratio in the stock presently is 19.93 and the short float percentage is 8.93% of 83.54 million shares floated in the market. The relative strength index of the stock is 50.14. The stock is currently 41.78% below its 52-week high of $4.93 and 79.37% above its 52-week low of $1.60. We see that the return on equity of the stock is negative of 164.19% and return on asset of the company is negative of 125.20%. The beta which is a measure of volatility of the stock is currently 1.45.

The company today announced the results of its drug Reolysin a cancer drug has met its preliminary goal of decreasing the tumors size in patients suffering from a type of skin cancer – metastatic melanoma.

How Should Investors Trade ONCY Now? Get the latest trends and data here.

U.S. Geothermal Inc. (NYSEMKT:HTM) opened the day at $0.40 and hit a high of $0.43 and a low of $0.38 and is currently down by 1.22% to trade at $0.380, with a volume of about 0.743 million. The insider have a stake of about 58.93% while the institutions have collected about 6.09% of the total 25.08 million shares outstanding. The short ratio in the stock presently is 6.35 and the short float percentage is 21.27% of 10.30 million shares floated in the market. The relative strength index of the stock is 60.10. The stock is currently 18.87% below its 52-week high of $0.48 and 49.77% above its 52-week low of $0.26. We see that the return on equity of the stock is negative of 62.26% and return on asset of the company is negative of 55.50%. The beta which is a measure of volatility of the stock is currently 1.32.

Is HTM a solid investment at these levels? Get valuable updates and exclusive insights here.

Disclosure:

WallStreetAnalyzed.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetAnalyzed.com website, for complete risks and disclosures.


About Beth Hart

Beth is from New York. She has two master’s degrees and served as a lecturer in B-School. Her master’s degree is an MBA in Global Management from the University of Phoenix (2010). She has worked for small businesses, public agencies, and large corporations. She does write articles as a freelancer.

View all post by Beth Hart

Write Your Comment